Finance

Lists
PPRE:IDX
PP Presisi Tbk PT
IDR 86.00
+1.18%
(+1.00) 1D
Oct 14, 4:08:06 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for PPRE...
Open
IDR 85
High
IDR 89
Low
IDR 84
Mkt. cap
879.29B
Avg. vol.
25.52M
Volume
22.31M
52-wk high
IDR 322
52-wk low
IDR 68
EPS
-IDR 159
Shares outstanding
10.22B
No. of employees
832
Open
IDR 85
High
IDR 89
Low
IDR 84
Mkt. cap
879.29B
Avg. vol.
25.52M
Volume
22.31M
52-wk high
IDR 322
52-wk low
IDR 68
EPS
-IDR 159
Shares outstanding
10.22B
No. of employees
832
News stories
From web sources and news partners
About PP Presisi Tbk PT
CEO-
Employees832
Founded2004
Headquarters-
SectorConstruction
Websitepp-presisi.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.12T
1.17T
1.18T
1.05T
Cost of goods sold
866.56B
1.88T
1.04T
958.02B
Cost of revenue
866.56B
1.88T
1.04T
958.02B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.69B
28.45B
17.45B
15.12B
Operating expense
31.42B
681.83B
41.22B
65.01B
Total operating expenses
897.97B
2.57T
1.08T
1.02T
Operating income
225.04B
-1.39T
101.53B
25.94B
Other non operating income
13.09B
-80.44B
-6.05B
18.27B
EBT including unusual items
151.61B
-1.51T
15.80B
-44.12B
EBT excluding unusual items
151.61B
-1.58T
15.80B
-44.12B
Income tax expense
32.31B
33.28B
31.76B
28.61B
Effective tax rate
21.31%
-2.20%
200.96%
-64.85%
Other operating expenses
4.59B
3.34B
4.40B
4.25B
Net income
100.35B
-1.57T
-46.18B
-116.61B
Net profit margin
8.94%
-133.47%
-3.92%
-11.12%
Earnings per share
-
-
-
-
Interest and investment income
2.20B
1.08B
8.19B
-
Interest expense
-88.73B
-114.21B
-84.77B
-88.72B
Net interest expenses
-86.52B
-113.13B
-76.58B
-88.72B
Depreciation and amortization charges
2.51B
3.04B
3.34B
3.38B
EBITDA
282.28B
-1.34T
171.25B
55.80B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps